Colombia Pharma and Healthcare Sector Report 2023-2024

Colombia was the fifth largest pharmaceutical market in Latin America in terms of sales value in 2021, due to its large and growing population. The country has a near-universal social security health insurance system, which has experienced chronic issues with funding. Its complete overhaul was being debated in the national congress as of August 2023. Moreover, Colombia has a relatively sizeable private health insurance market, the fourth largest in Latin America in terms of market value in 2022. Partly as a result of the COVID-19 pandemic, healthcare spending in both the private and public segments surged massively in 2021. Nonetheless, many structural deficiencies and imbalances persist, especially regarding the distribution of the medical workforce, the significant dependence on imports of drugs in order to satisfy the needs of the domestic pharmaceutical market, and the ballooning debt of players in the social security health insurance system to healthcare services providers.

This report provides a complete and detailed analysis of the "Healthcare and pharma" sector for Colombia. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the "Healthcare and pharma" sector in Colombia
• Crystallise the forces both driving and restraining this sector in Colombia
• Ascertain Colombia’s position in the global sector
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in Colombia.
• Build a clear picture of trends, output and consumption for specific sub-sectors